Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.3 USD | +1.91% | -1.68% | -2.53% |
Apr. 19 | UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept | MT |
Apr. 18 | Correction to Health Care Roundup Article | DJ |
Financials (USD)
Sales 2024 * | 41.69B | Sales 2025 * | 44.76B | Capitalization | 186B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.17B | EV / Sales 2024 * | 4.6 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 913M | EV / Sales 2025 * | 4.14 x |
P/E ratio 2024 * |
31.3
x | P/E ratio 2025 * |
26.8
x | Employees | 114,000 |
Yield 2024 * |
2.02% | Yield 2025 * |
2.16% | Free-Float | 86.77% |
Latest transcript on Abbott Laboratories
1 day | +1.91% | ||
1 week | -1.68% | ||
Current month | -5.61% | ||
1 month | -5.20% | ||
3 months | -6.46% | ||
6 months | +12.41% | ||
Current year | -2.53% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +1.40% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 107.3 | +1.91% | 10,533,616 |
24-04-18 | 105.3 | -0.59% | 7,306,449 |
24-04-17 | 105.9 | -3.03% | 12,002,886 |
24-04-16 | 109.2 | +0.29% | 7,283,867 |
24-04-15 | 108.9 | -0.20% | 4,595,628 |
Delayed Quote Nyse, April 19, 2024 at 04:01 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.53% | 186B | |
-3.52% | 106B | |
+5.33% | 50.39B | |
+16.43% | 47.65B | |
-1.73% | 39.29B | |
+5.66% | 27.24B | |
-2.01% | 25.42B | |
+9.84% | 24.39B | |
-1.87% | 24.54B | |
+9.12% | 22.5B |
- Stock Market
- Equities
- ABT Stock